Joseph L. Nates

ORCID: 0000-0002-3190-3670
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Palliative Care and End-of-Life Issues
  • Sepsis Diagnosis and Treatment
  • Cardiac, Anesthesia and Surgical Outcomes
  • Family and Patient Care in Intensive Care Units
  • Cardiac Arrest and Resuscitation
  • Neutropenia and Cancer Infections
  • Intensive Care Unit Cognitive Disorders
  • Emergency and Acute Care Studies
  • Tracheal and airway disorders
  • Disaster Response and Management
  • Respiratory Support and Mechanisms
  • Hematological disorders and diagnostics
  • Trauma and Emergency Care Studies
  • COVID-19 Clinical Research Studies
  • Airway Management and Intubation Techniques
  • Venous Thromboembolism Diagnosis and Management
  • Esophageal and GI Pathology
  • Health Systems, Economic Evaluations, Quality of Life
  • Pancreatic and Hepatic Oncology Research
  • Case Reports on Hematomas
  • Childhood Cancer Survivors' Quality of Life
  • Frailty in Older Adults
  • CAR-T cell therapy research
  • COVID-19 and healthcare impacts
  • Cancer Immunotherapy and Biomarkers

The University of Texas MD Anderson Cancer Center
2016-2025

Central Council for Research in Yoga & Naturopathy
2022

National Institutes of Health
2022

Pain and Rehabilitation Medicine
2022

University of Houston
2022

Anne Arundel Medical Center
2021

Pontificia Universidad Javeriana
2020

Fundación Santa Fe de Bogotá
2020

Community Link
2020

Baylor College of Medicine
2020

Objectives: To update the Society of Critical Care Medicine’s guidelines for ICU admission, discharge, and triage, providing a framework clinical practice, development institutional policies, further research. Design: An appointed Task Force followed standard, systematic, evidence-based approach in reviewing literature to develop these guidelines. Measurements Main Results: The assessment evidence recommendations was based on principles Grading Recommendations Assessment, Development...

10.1097/ccm.0000000000001856 article EN Critical Care Medicine 2016-07-16

<h3>Importance</h3> End-of-life decisions occur daily in intensive care units (ICUs) around the world, and these practices could change over time. <h3>Objective</h3> To determine changes end-of-life European ICUs after 16 years. <h3>Design, Setting, Participants</h3> Ethicus-2 was a prospective observational study of 22 previously included Ethicus-1 (1999-2000). During self-selected continuous 6-month period at each ICU, consecutive patients who died or had any limitation life-sustaining...

10.1001/jama.2019.14608 article EN JAMA 2019-10-02

Coronavirus disease 2019 patients are currently overwhelming the world's healthcare systems. This article provides practical guidance to front-line physicians forced make critical rationing decisions.

10.1097/ccm.0000000000004410 article EN Critical Care Medicine 2020-05-06

The coronavirus disease 2019 (COVID-19) pandemic has prompted expanded use of prone positioning for refractory hypoxemia. Clinical trials have demonstrated beneficial effects early acute respiratory distress syndrome (ARDS), including decreased mortality. However, pregnant women were excluded from these trials. To address the need low-cost, low-harm interventions in face a widespread viral wherein hypoxemia predominates, we developed an algorithm both intubated and nonintubated women. This...

10.1097/aog.0000000000004012 article EN Obstetrics and Gynecology 2020-06-09

To investigate the prognostic value of Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) in patients who received transplantation admitted to intensive care unit (ICU).We investigated association HCT-CI with inpatient mortality and overall survival (OS) among 377 were ICU within 100 days allogeneic stem-cell (ASCT) at our institution. scores collapsed into four groups evaluated univariate multivariate analyses using logistic regression Cox proportional hazards models.The...

10.1200/jco.2013.50.5867 article EN Journal of Clinical Oncology 2013-10-15

To describe short-term outcomes and independent predictors of 28-dayx mortality in adult patients with hematologic malignancies septic shock defined by the new Third International Consensus Definitions (Sepsis-3) criteria.We performed a retrospective cohort study admitted to medical ICU from April 2016 March 2019. Demographic clinical features were collected. We used descriptive statistics summarize patient characteristics, logistic regression identify 28-day mortality, Kaplan-Meier plots...

10.6004/jnccn.2021.7046 article EN Journal of the National Comprehensive Cancer Network 2022-01-01

Catheters coated with minocycline and rifampin are proven to decrease the rates of central line-associated bloodstream infection; however, it is unclear whether success occurs independent other infection control precautions. We evaluated effect catheters without precautions on our in critically ill patients antibiotic resistance throughout hospital intensive care unit.Retrospective clinical cohort study conducted during 1999-2006 an observational laboratory component.A tertiary...

10.1097/ccm.0b013e3181feb83e article EN Critical Care Medicine 2010-11-06

To investigate ICU utilization and hospital outcomes of oncological patients admitted to a comprehensive cancer center.Observational cohort study.The University Texas MD Anderson Cancer Center.Consecutive adults with discharged over 20-year period.None.The Cochran-Armitage test for trend was used evaluate mortality rates by primary service time. A negative binomial log linear regression model fitted the data length stay Among 387,306 adult hospitalized patients, rate 12.9%. The overall 3.6%:...

10.1097/ccm.0000000000001568 article EN Critical Care Medicine 2016-01-15

Resistant Gram-negative bacteria are increasing central-line-associated bloodstream infection threats. To better combat this, chlorhexidine (CHX) was added to minocycline-rifampin (M/R) catheters. The in vitro antimicrobial activity of CHX-M/R catheters against multidrug resistant, Acinetobacter baumannii, Enterobacter cloacae, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia tested. M/R CHX-silver sulfadiazine (CHX/SS) were used as...

10.1128/aac.01959-13 article EN Antimicrobial Agents and Chemotherapy 2013-10-29
Coming Soon ...